Rick Whittingham
Chief Executive Officer
Replay available
Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call
Theravance Biopharma, Inc. (NASDAQ: TBPH) Q3 2024 earnings conference call, held 2024-11-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Rhonda Farnham
Chief Business Officer
Aziz Swaf
Chief Financial Officer
Anya Miller
Head of Development
Julian Harrison
Analyst, BTIG
Ernie Rodriguez
Analyst, TD Cowan
Douglas Sile
Analyst, AC Rainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Theravance Biopharma, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.487 -- 00:00:03.752 Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the TheraVance 00:00:03.752 -- 00:00:07.017 BioPharma third quarter 2024 conference call. 00:00:07.017 -- 00:00:10.202 During the presentation, all participants will be in a listen-only mode. 00:00:10.202 -- 00:00:13.867 A question and answer session will follow the company's formal remarks. 00:00:13.867 -- 00:00:19.055 To ask a question, press the star key followed by the digit 1, digit 1 on your phone. 00:00:19.055 -- 00:00:21.359 Again, that's star 1, 1 to ask a question. 00:00:21.359 -- 00:00:26.146 If listening via webcast, please mute your audio on your webcast device before asking 00:00:26.146 -- 00:00:30.337 a question. over the phone. I'll repeat the instructions after management completes their 00:00:30.337 -- 00:00:33.882 prepared remarks. Also, today's conference call is being recorded. 00:00:33.882 -- 00:00:37.427 And now I'd like to turn the conference over to Rick Whittingham, Chief Executive Officer. 00:00:37.427 -- 00:00:40.028 Please go ahead, sir. 00:00:41.072 -- 00:00:46.140 Good afternoon, and welcome to Theravance Myocardia's third quarter 2024 earnings 00:00:46.140 -- 00:00:51.328 results conference call. I encourage you to review our forward-looking statements disclaimer 00:00:51.328 -- 00:00:56.752 on slide two, which covers certain risk factors which could cause actual results 00:00:56.752 -- 00:01:01.319 to differ materially from any forward-looking statements that we might make in today's 00:01:01.319 -- 00:01:06.968 call, and which are described further in our filings with the SEC. 00:01:06.968 -- 00:01:12.016 You will find today's agenda on slide three, along with members of the TheraVance leadership 00:01:12.016 -- 00:01:15.241 team...